
### [MONDO:0020104](http://purl.obolibrary.org/obo/MONDO_0020104)
**Label:** rare constitutional hemolytic anemia due to an enzyme disorder

**Subclasses:** [MONDO:0010392](http://purl.obolibrary.org/obo/MONDO_0010392) (glycogen storage disease due to phosphoglycerate kinase 1 deficiency), [MONDO:0009295](http://purl.obolibrary.org/obo/MONDO_0009295) (glycogen storage disease VII), [MONDO:0009284](http://purl.obolibrary.org/obo/MONDO_0009284) (glutathione synthetase deficiency without 5-oxoprolinuria), [MONDO:0009340](http://purl.obolibrary.org/obo/MONDO_0009340) (non-spherocytic hemolytic anemia due to hexokinase deficiency), [MONDO:0018750](http://purl.obolibrary.org/obo/MONDO_0018750) (class i glucose-6-phosphate dehydrogenase deficiency), [MONDO:0019531](http://purl.obolibrary.org/obo/MONDO_0019531) (hemolytic anemia due to glutathione reductase deficiency), [MONDO:0009113](http://purl.obolibrary.org/obo/MONDO_0009113) (hemolytic anemia due to diphosphoglycerate mutase deficiency), [MONDO:0014221](http://purl.obolibrary.org/obo/MONDO_0014221) (triosephosphate isomerase deficiency), [MONDO:0013275](http://purl.obolibrary.org/obo/MONDO_0013275) (hemolytic anemia due to glucophosphate isomerase deficiency), [MONDO:0009950](http://purl.obolibrary.org/obo/MONDO_0009950) (pyruvate kinase deficiency of red cells), [MONDO:0009259](http://purl.obolibrary.org/obo/MONDO_0009259) (gamma-glutamylcysteine synthetase deficiency), [MONDO:0020105](http://purl.obolibrary.org/obo/MONDO_0020105) (hemolytic anemia due to hexose monophosphate shunt and glutathione metabolism anomalies), [MONDO:0020457](http://purl.obolibrary.org/obo/MONDO_0020457) (6-phosphogluconate dehydrogenase deficiency), [MONDO:0020458](http://purl.obolibrary.org/obo/MONDO_0020458) (hemolytic anemia due to erythrocyte adenosine deaminase overproduction), [MONDO:0020106](http://purl.obolibrary.org/obo/MONDO_0020106) (hemolytic anemia due to a disorder of glycolytic enzymes), [MONDO:0009946](http://purl.obolibrary.org/obo/MONDO_0009946) (hemolytic anemia due to pyrimidine 5' nucleotidase deficiency), [MONDO:0009902](http://purl.obolibrary.org/obo/MONDO_0009902) (cutaneous porphyria), [MONDO:0020107](http://purl.obolibrary.org/obo/MONDO_0020107) (hemolytic anemia due to an erythrocyte nucleotide metabolism disorder), [MONDO:0009947](http://purl.obolibrary.org/obo/MONDO_0009947) (glutathione synthetase deficiency with 5-oxoprolinuria), [MONDO:0017909](http://purl.obolibrary.org/obo/MONDO_0017909) (glutathione synthetase deficiency), [MONDO:0012967](http://purl.obolibrary.org/obo/MONDO_0012967) (hemolytic anemia due to adenylate kinase deficiency), [MONDO:0012747](http://purl.obolibrary.org/obo/MONDO_0012747) (glycogen storage disease due to aldolase a deficiency), [MONDO:0016626](http://purl.obolibrary.org/obo/MONDO_0016626) (hemolytic anemia due to glyceraldehyde-3-phosphate dehydrogenase deficiency), 

**Corr. equiv. classes:** [Orphanet:86817](http://www.orpha.net/ORDO/Orphanet_86817), [OMIM:222800](http://purl.obolibrary.org/obo/OMIM_222800), [Orphanet:57](http://www.orpha.net/ORDO/Orphanet_57), [OMIM:266120](http://purl.obolibrary.org/obo/OMIM_266120), [Orphanet:99135](http://www.orpha.net/ORDO/Orphanet_99135), [Orphanet:289849](http://www.orpha.net/ORDO/Orphanet_289849), [Orphanet:289846](http://www.orpha.net/ORDO/Orphanet_289846), [Orphanet:32](http://www.orpha.net/ORDO/Orphanet_32), [OMIM:266200](http://purl.obolibrary.org/obo/OMIM_266200), [OMIM:235700](http://purl.obolibrary.org/obo/OMIM_235700), [OMIM:230450](http://purl.obolibrary.org/obo/OMIM_230450), [OMIM:611881](http://purl.obolibrary.org/obo/OMIM_611881), [Orphanet:248305](http://www.orpha.net/ORDO/Orphanet_248305), [OMIM:612631](http://purl.obolibrary.org/obo/OMIM_612631), [OMIM:263700](http://purl.obolibrary.org/obo/OMIM_263700), [Orphanet:713](http://www.orpha.net/ORDO/Orphanet_713), [Orphanet:712](http://www.orpha.net/ORDO/Orphanet_712), [Orphanet:90030](http://www.orpha.net/ORDO/Orphanet_90030), [Orphanet:714](http://www.orpha.net/ORDO/Orphanet_714), [Orphanet:90031](http://www.orpha.net/ORDO/Orphanet_90031), [Orphanet:33574](http://www.orpha.net/ORDO/Orphanet_33574), [Orphanet:79277](http://www.orpha.net/ORDO/Orphanet_79277), [Orphanet:466026](http://www.orpha.net/ORDO/Orphanet_466026), [Orphanet:98374](http://www.orpha.net/ORDO/Orphanet_98374), [OMIM:266130](http://purl.obolibrary.org/obo/OMIM_266130), [Orphanet:371](http://www.orpha.net/ORDO/Orphanet_371), [Orphanet:98370](http://www.orpha.net/ORDO/Orphanet_98370), [Orphanet:98372](http://www.orpha.net/ORDO/Orphanet_98372), [OMIM:231900](http://purl.obolibrary.org/obo/OMIM_231900), [OMIM:300653](http://purl.obolibrary.org/obo/OMIM_300653), [OMIM:613470](http://purl.obolibrary.org/obo/OMIM_613470), [OMIM:232800](http://purl.obolibrary.org/obo/OMIM_232800), [OMIM:615512](http://purl.obolibrary.org/obo/OMIM_615512), [Orphanet:868](http://www.orpha.net/ORDO/Orphanet_868), [Orphanet:766](http://www.orpha.net/ORDO/Orphanet_766), [Orphanet:99138](http://www.orpha.net/ORDO/Orphanet_99138), [Orphanet:35120](http://www.orpha.net/ORDO/Orphanet_35120), 

**Class expressions from DL-Learner:**

- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 42.04%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) 42.04%
- [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 41.19%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) 41.19%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) 37.72%
- [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 37.63%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 37.63%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) 35.56%
- [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) 35.05%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 34.83%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 31.38%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 29.31%
- Thing 29.30%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 29.30%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 22.52%


